TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9112275

Group type: EXPERIMENTAL
Intervention: Skin type V (heavily pigmented individuals)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Skin types I and II (fair-skinned individuals)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Skin type V
Number of subjects: 2
Study: 1742583

Group type: EXPERIMENTAL
Intervention: Lunar DPX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hologic QDR-1000
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lunar DPX and Hologic QDR-1000
Number of subjects: 0
Study: 7038189

Group type: EXPERIMENTAL
Intervention: Cefroxadine (CXD) at doses of 5, 10, and 20 mg/kg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Cefroxadine (CXD)
Number of subjects: 151
Study: 31116312

Group type: EXPERIMENTAL
Intervention: Segmented and plastic hemorrhoidectomy (SPH)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Milligan‐Morgan hemorrhoidectomy (Control)
Number of subjects: 300
Study: 28251822

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 26949924

Group type: EXPERIMENTAL
Intervention: Psychoeducation text focusing on medication
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Psychoeducation text focusing on CBT
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Psychoeducation text focusing on psychodynamic therapy
Number of subjects: 178
Study: 22508760

Group type: EXPERIMENTAL
Intervention: LDX (n = 17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 15)
Number of subjects: 32
Study: 22120995

Group type: EXPERIMENTAL
Intervention: Coroflex™ Please stents
Number of subjects: 319

Group type: COMPARATOR
Intervention: Taxus™ Liberte stents
Number of subjects: 319
Study: 20412274

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg twice daily for 4 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pioglitazone 30 mg daily for 4 months
Number of subjects: 40
Study: 17394963

Group type: EXPERIMENTAL
Intervention: Stepwise catheter ablation of chronic AF
Number of subjects: 40
Study: 16277141

Group type: EXPERIMENTAL
Intervention: Treatment optimism
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Outcome expectations
Number of subjects: 76
Study: 12452499

Group type: EXPERIMENTAL
Intervention: 1.2% triclocarban-containing soap
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo soap
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard practice controls
Number of subjects: 162
Study: 9627917

Group type: EXPERIMENTAL
Intervention: Almond-based diet
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Olive oil-based diet
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dairy-based control diet
Number of subjects: 45
Study: 7667020

Group type: EXPERIMENTAL
Intervention: Acuvue lenses (58% ionic)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Permaflex lenses (74% non‐ionic)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: All three lenses (Medalist, Acuvue, Permaflex)
Number of subjects: 19
Study: 2913837

Group type: EXPERIMENTAL
Intervention: Prenatal self-help smoking cessation program (8-week serialized program)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 242
Study: 30012494

Group type: EXPERIMENTAL
Intervention: Low-literacy chronic pain self-management program delivered in 6 sessions of 1-on-1 meetings with a trained health educator
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Low-literacy chronic pain self-management program delivered in 8 group lectures by experts
Number of subjects: 111

Group type: COMPARATOR
Intervention: Both arms of the intervention (1-on-1 and group lectures)
Number of subjects: 111
Study: 28342943

Group type: EXPERIMENTAL
Intervention: Antipsychotics for schizophrenia
Number of subjects: 1807

Group type: EXPERIMENTAL
Intervention: Perceived treatability and belief in effectiveness of treatment for schizophrenia
Number of subjects: 1807

Group type: EXPERIMENTAL
Intervention: Perceived treatability and belief in effectiveness of treatment for depression
Number of subjects: 1807

Group type: COMPARATOR
Intervention: Somatic illnesses
Number of subjects: 1807
Study: 26651484

Group type: EXPERIMENTAL
Intervention: Behavior change strategy consisting of one individual theoretical counseling session plus eight twice-a-week individual theoretical and practical exercise counseling sessions for 3 years.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care including general physician recommendations for daily PA.
Number of subjects: 300
Study: 23179024

Group type: EXPERIMENTAL
Intervention: Dysphagic DMD patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27

Group type: COMPARATOR
Intervention: Preserved swallow function DMD patients
Number of subjects: 27
Study: 21349479

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 19036671

Group type: EXPERIMENTAL
Intervention: Tigecycline 100 mg/day (100 mg initial dose, then 50 mg intravenously twice daily)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Vancomycin 2 g/day (1 g intravenously twice daily) and Aztreonam 4 g/day (2 g intravenously twice daily)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 546

Group type: COMPARATOR
Intervention: Vancomycin/Aztreonam
Number of subjects: 546
Study: 16609033

Group type: EXPERIMENTAL
Intervention: High LET carbon beam therapy
Number of subjects: 49
Study: 12900739

Group type: EXPERIMENTAL
Intervention: PRE-NORM interpretation of SPECT images
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: POST-NORM interpretation of SPECT images
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (single-vessel CAD)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (no significant angiographic CAD)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (normalcy group)
Number of subjects: 258
Study: 10971327

Group type: EXPERIMENTAL
Intervention: Alcohol-based disinfectant
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-antiseptic soap
Number of subjects: 52
Study: 8929043

Group type: EXPERIMENTAL
Intervention: Ketorolac infusion (150 mg in 60 ml isotonic chlorinated solution at 0.5 ml/h + 4 bolus/h of 0.5 ml)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Morphine infusion (60 ml in 60 ml isotonic chlorinated solution at the same rate)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (60 ml isotonic chlorinated solution + Ketorolac intramuscular on demand)
Number of subjects: 36
Study: 1639742

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment
Number of subjects: 785

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 785
Study: 6375805

Group type: EXPERIMENTAL
Intervention: Cicloxolone cream
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Carbenoxolone cream
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 31393176

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) for 2 weeks
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 1800
Study: 30219432

Group type: EXPERIMENTAL
Intervention: Psyllium (10 g pre-mixed in cookies twice per day for 12 weeks)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Psyllium
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27004570

Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg IV)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Radium-223 and Placebo
Number of subjects: 206
Study: 24519768

Group type: EXPERIMENTAL
Intervention: Mammography (five annual mammography screens)
Number of subjects: 89835

Group type: COMPARATOR
Intervention: Control (no mammography)
Number of subjects: 89835
Study: 22500643

Group type: EXPERIMENTAL
Intervention: Pricking blood at Neiyingxiang (ExHN 9)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Acupuncture treatment at Waiyingxiang (LI 20)
Number of subjects: 50
Study: 20605871

Group type: EXPERIMENTAL
Intervention: CPB with low tidal volume ventilation (3 ml.kg(‐1)) without positive end expiratory pressure (PEEP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (no ventilation during CPB)
Number of subjects: 40
Study: 17433950

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of enalaprilat
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15818198

Group type: EXPERIMENTAL
Intervention: 1-year cognitive-behavioral stress management program
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 166
Study: 11971197

Group type: EXPERIMENTAL
Intervention: New treatment schedule of melarsoprol (10 daily doses of 2.16 mg/kg)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard treatment protocol of melarsoprol (3 series of 3-4 injections every 24 hours)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: New treatment schedule of melarsoprol
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard treatment protocol of melarsoprol
Number of subjects: 500
Study: 9565948

Group type: EXPERIMENTAL
Intervention: Long-bout exercise condition (30 min continuous session per day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Short-bout exercise condition (three 10-min sessions per day)
Number of subjects: 50
Study: 7797653

Group type: EXPERIMENTAL
Intervention: Individual cognitive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group cognitive therapy
Number of subjects: 0
Study: 1972434

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.1‐0.2 mg/kg) administered by rapid injection (30 s)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.1‐0.2 mg/kg) administered by slow infusion (20‐30 min)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 13
Study: 354373

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 45

Group type: COMPARATOR
Intervention: Neomycin-sorbitol
Number of subjects: 45
Study: 30905614

Group type: EXPERIMENTAL
Intervention: Clementines (1 kg/d)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Clementine juice (chronic consumption)
Number of subjects: 2
Study: 29127080

Group type: EXPERIMENTAL
Intervention: 24 mg ENDS
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 16 mg ENDS
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both ENDS groups
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Cessation behaviors (quit attempts, biologically verified abstinence)
Number of subjects: 68
Study: 26578308

Group type: EXPERIMENTAL
Intervention: Common beans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cowpeas
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard complementary food
Number of subjects: 0
Study: 23145889

Group type: EXPERIMENTAL
Intervention: Self-reported recommendations for follow-up after abnormal Pap tests
Number of subjects: 519

Group type: COMPARATOR
Intervention: Health department recommendations for follow-up after abnormal Pap tests
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Receiving a letter stating the results of the Pap test
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Referral to a gynecologist for follow-up
Number of subjects: 519
Study: 21555982

Group type: EXPERIMENTAL
Intervention: Training the healthy hand to execute the nine hole peg test 10 times a day for three consecutive days.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no training).
Number of subjects: 20
Study: 18438407

Group type: EXPERIMENTAL
Intervention: SNP rs4415084
Number of subjects: 6145

Group type: EXPERIMENTAL
Intervention: SNP rs10941679
Number of subjects: 6145

Group type: EXPERIMENTAL
Intervention: FGFR2 signal
Number of subjects: 6145
Study: 15774846

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg rhCC10
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 5 mg/kg rhCC10
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 11893369

Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acid‐enriched diets
Number of subjects: 15806
Study: 10211913

Group type: EXPERIMENTAL
Intervention: Zatosetron 0.2 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Zatosetron 1 mg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Zatosetron 5 mg
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 7789938

Group type: EXPERIMENTAL
Intervention: McCanse Readiness for Death Instrument (MRDI) administered to terminally-ill individuals
Number of subjects: 70

Group type: COMPARATOR
Intervention: McCanse Readiness for Death Instrument (MRDI) administered to cardiac-impaired individuals (control group)
Number of subjects: 70
Study: 1975995

Group type: EXPERIMENTAL
Intervention: esmolol
Number of subjects: 20
Study: 354312

Group type: EXPERIMENTAL
Intervention: 1 g of calcium per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31471436

Group type: EXPERIMENTAL
Intervention: Home-based computerised cognitive training (CCT) with exercises targeting memory, matching, spatial recognition, processing speed for 12 weeks followed by booster sessions up to 78 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Home-based active control condition (computerised crossword puzzle training (CPT)) for 12 weeks followed by booster sessions up to 78 weeks.
Number of subjects: 100
Study: 28975634

Group type: EXPERIMENTAL
Intervention: CTI ablation with continuous reevaluation of the CTI block during 30 minutes (WT+ group)
Number of subjects: 319

Group type: COMPARATOR
Intervention: CTI ablation with no waiting period after proven bidirectional CTI block (WT- group)
Number of subjects: 319
Study: 26015558

Group type: EXPERIMENTAL
Intervention: Behavioral Family Systems Therapy for Diabetes (BFST‐D)
Number of subjects: 0
Study: 23624336

Group type: EXPERIMENTAL
Intervention: Adolescents (15-17 years)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Adults (25-30 years)
Number of subjects: 2
Study: 21977379

Group type: EXPERIMENTAL
Intervention: Rivastigmine patch (9.5 mg/24-h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivastigmine capsules (12 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19122080

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution at a rate of 5 mL/sec through an 18-gauge needle at the inferomedial location
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution at a rate of 5 mL/sec through an 18-gauge needle at the superomedial location
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution to diagnose 50% of arthrotomies
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution to diagnose 75% of arthrotomies
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution to diagnose 90% of arthrotomies
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution to diagnose 95% of arthrotomies
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Injection of normal saline solution to diagnose 99% of arthrotomies
Number of subjects: 56
Study: 17222324

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg at bedtime
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 15605774

Group type: EXPERIMENTAL
Intervention: Karinat (antioxidant dietary supplement)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 11556943

Group type: EXPERIMENTAL
Intervention: One‐Minute Preceptor (OMP) intervention, 1‐hour session with lecture, group discussion, and role‐play
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: One‐Minute Preceptor (OMP) intervention
Number of subjects: 57
Study: 9786536

Group type: EXPERIMENTAL
Intervention: Sublingual hyoscyamine sulfate (0.125 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intravenous ketorolac tromethamine (30 mg)
Number of subjects: 54
Study: 7602722

Group type: COMPARATOR
Intervention: Standard diet (Nutrodrip Standard)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Diet supplemented with 20 g of soluble fiber (partially hydrolyzed guar gum, Sunfiber)
Number of subjects: 100
Study: 3048467

Group type: EXPERIMENTAL
Intervention: melphalan + TBI
Number of subjects: 63

Group type: COMPARATOR
Intervention: CY/TBI
Number of subjects: 63
Study: 27819483

Group type: EXPERIMENTAL
Intervention: Music-with-movement (MM) intervention (n = 58)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Music listening (ML) (n = 54)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Social activity (SA) (n = 53)
Number of subjects: 165
Study: 27303746

Group type: EXPERIMENTAL
Intervention: Triclosan- and triclocarban (TCS)-containing HPCPs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-triclosan/triclocarban (nTCS)-containing HPCPs
Number of subjects: 0
Study: 26048955

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recovery Sleep
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short Testing after Sleep Deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recovery Sleep for Finger Motor Responses
Number of subjects: 0
Study: 23456214

Group type: EXPERIMENTAL
Intervention: Planning intervention (implementation intention)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Spontaneously generated action plans about snacking
Number of subjects: 144
Study: 20859301

Group type: EXPERIMENTAL
Intervention: diet (D)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: exercise (E)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: diet and exercise (DE)
Number of subjects: 157

Group type: COMPARATOR
Intervention: control (C)
Number of subjects: 157
Study: 18338278

Group type: EXPERIMENTAL
Intervention: TENS therapy (20 minutes, 15 sessions over 3 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo stimulation (15 sessions over 3 weeks)
Number of subjects: 19
Study: 15313089

Group type: EXPERIMENTAL
Intervention: Videotape intervention
Number of subjects: 581

Group type: COMPARATOR
Intervention: Pamphlet control
Number of subjects: 581
Study: 11263625

Group type: EXPERIMENTAL
Intervention: Primary stenting
Number of subjects: 123

Group type: COMPARATOR
Intervention: Accelerated t-PA
Number of subjects: 123
Study: 9683949

Group type: EXPERIMENTAL
Intervention: Intravenous teicoplanin (5 patients each at 1 h, 12 h, 24 h pre-operatively, and 24 h and 48 h pre-operatively)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Topical teicoplanin drops (5 patients, half-hourly for 6 h before vitrectomy)
Number of subjects: 25
Study: 7810633

Group type: EXPERIMENTAL
Intervention: Oligopeptides
Number of subjects: 12

Group type: COMPARATOR
Intervention: Whole casein
Number of subjects: 12
Study: 3061441

Group type: EXPERIMENTAL
Intervention: Dithranol and fluocinonide in Lassar's paste
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dithranol in Lassar's paste
Number of subjects: 24
Study: 28155101

Group type: EXPERIMENTAL
Intervention: Moderate intermittent hypoxia (IH) - 10 sessions over 2 weeks, 70 min per session
Number of subjects: 6
Study: 26848765

Group type: EXPERIMENTAL
Intervention: High protein/low carbohydrate diet (diet HP)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard hypocaloric diet (diet S)
Number of subjects: 283
Study: 24702251

Group type: EXPERIMENTAL
Intervention: Hydralazine (83 mg for slow acetylators, 182 mg for fast acetylators)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Valproate (700 mg every 8 hours)
Number of subjects: 12
Study: 21929846

Group type: EXPERIMENTAL
Intervention: escitalopram or nortriptyline
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: citalopram
Number of subjects: 811
Study: 20540172

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 99

Group type: COMPARATOR
Intervention: LMA ProSeal
Number of subjects: 99
Study: 17008798

Group type: EXPERIMENTAL
Intervention: Active EECP therapy
Number of subjects: 30
Study: 16120091

Group type: EXPERIMENTAL
Intervention: HMR 1031 (20 mg b.i.d.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study: 11572294

Group type: EXPERIMENTAL
Intervention: Carbide bur #8 round
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Diamond bur #801
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: KCP 1000 air abrasion unit
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sonicsys Approx.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Carbide bur plus air abrasive
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Carbide bur plus laser
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Laser without etching
Number of subjects: 72
Study: 9451475

Group type: EXPERIMENTAL
Intervention: Pravastatin, 20 mg/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 7938368

Group type: EXPERIMENTAL
Intervention: Autogenic training (6 sessions à 90 minutes)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hypnosis (6 sessions à 90 minutes)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Autogenic training and hypnosis
Number of subjects: 27
Study: 3131256

Group type: EXPERIMENTAL
Intervention: Fat infusion (1.2 g fat/kg B.W./day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbohydrates alone covering total energy expenditure
Number of subjects: 0
Study: 30658676

Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Heated Humidified High-Flow Nasal Cannula (HHHFNC)
Number of subjects: 141
Study: 28600309

Group type: EXPERIMENTAL
Intervention: Dulce Digital intervention (up to three motivational, educational, and/or call-to-action text messages per day over 6 months)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Dulce Digital intervention
Number of subjects: 126
Study: 26749228

Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg, 600 mg 8 hours before and 600 mg 2 hours before anesthesia induction)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (talc powder)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg)
Number of subjects: 58